We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
(-3.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Leggett & Platt
LEG
$1.32B
| $801K | ﹤0.01% |
24,840
-242,599
| -91% | -$8.17M |
|
2652
Heritage Financial
HFWA
$1.23B
| $801K | ﹤0.01% |
+26,128
| New | +$817K |
|
2653
Insmed
INSM
$27.6B
| $800K | ﹤0.01% |
40,035
-346,270
| -90% | -$6.69M |
|
2654
A.O. Smith
AOS
$8.49B
| $799K | ﹤0.01% |
13,954
-78,919
| -85% | -$4.41M |
|
|
PRO
2655
DELISTED
PROS Holdings
PRO
| $798K | ﹤0.01% |
32,903
+8,226
| +33% | +$202K |
|
2656
PUT
Kraft Heinz
KHC
$30.1B
| $798K | ﹤0.01% |
19,600
| – | – |
|
2657
Endava
DAVA
$167M
| $798K | ﹤0.01% |
10,430
-23,847
| -70% | -$1.77M |
|
2658
PUT
PepsiCo
PEP
$192B
| $795K | ﹤0.01% |
+4,400
| New | +$785K |
|
2659
Universal Logistics Holdings
ULH
$518M
| $795K | ﹤0.01% |
23,764
-758
| -3% | -$26.5K |
|
2660
CALL
Guidewire Software
GWRE
$15.2B
| $795K | ﹤0.01% |
+12,700
| New | +$754K |
|
2661
AstraZeneca
AZN
$244B
| $791K | ﹤0.01% |
5,831
-8,932
| -61% | -$1.12M |
|
2662
Aegon
AEG
$13.9B
| $791K | ﹤0.01% |
156,869
+55,785
| +55% | +$258K |
|
2663
Univest Financial
UVSP
$1.19B
| $789K | ﹤0.01% |
30,195
+10,464
| +53% | +$281K |
|
|
VHAQ
2664
DELISTED
Viveon Health Acquisition Corp.
VHAQ
| $789K | ﹤0.01% |
+74,068
| New | +$772K |
|
|
CXAC
2665
DELISTED
C5 Acquisition Corporation
CXAC
| $787K | ﹤0.01% |
77,047
-320
| -0.4% | -$3.23K |
|
2666
Castle Biosciences
CSTL
$933M
| $787K | ﹤0.01% |
33,434
-20,159
| -38% | -$467K |
|
|
WNS
2667
DELISTED
WNS Holdings
WNS
| $785K | ﹤0.01% |
9,808
-1,882
| -16% | -$155K |
|
|
VRAY
2668
DELISTED
ViewRay, Inc.
VRAY
| $784K | ﹤0.01% |
174,899
+110,073
| +170% | +$479K |
|
2669
Central Pacific Financial
CPF
$1B
| $781K | ﹤0.01% |
38,517
-5,774
| -13% | -$119K |
|
2670
CALL
MarketAxess Holdings
MKTX
$5.72B
| $781K | ﹤0.01% |
2,800
-700
| -20% | -$180K |
|
|
SAGE
2671
DELISTED
Sage Therapeutics
SAGE
| $777K | ﹤0.01% |
20,384
-8,450
| -29% | -$323K |
|
2672
Tencent Music
TME
$14.2B
| $776K | ﹤0.01% |
93,714
-38,310
| -29% | -$215K |
|
2673
RXO
RXO
$3.85B
| $775K | ﹤0.01% |
+45,042
| New | +$799K |
|
|
ANSS
2674
CALL
DELISTED
Ansys
ANSS
| $773K | ﹤0.01% |
+3,200
| New | +$745K |
|
2675
Enviri
NVRI
$564M
| $773K | ﹤0.01% |
122,894
-191,145
| -61% | -$1.14M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.